Hikma Pharmaceuticals PLC (HKMPY)
50.90
-0.65
(-1.26%)
USD |
OTCM |
May 17, 16:00
Hikma Pharmaceuticals Market Cap: 5.647B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 5.647B |
| May 16, 2024 | 5.719B |
| May 15, 2024 | 5.719B |
| May 14, 2024 | 5.556B |
| May 13, 2024 | 5.556B |
| May 10, 2024 | 5.556B |
| May 09, 2024 | 5.436B |
| May 08, 2024 | 5.436B |
| May 07, 2024 | 5.436B |
| May 06, 2024 | 5.436B |
| May 03, 2024 | 5.438B |
| May 02, 2024 | 5.438B |
| May 01, 2024 | 5.121B |
| April 30, 2024 | 5.159B |
| April 29, 2024 | 5.159B |
| April 26, 2024 | 5.159B |
| April 25, 2024 | 5.159B |
| April 24, 2024 | 5.159B |
| April 23, 2024 | 5.159B |
| April 22, 2024 | 5.159B |
| April 19, 2024 | 5.159B |
| April 18, 2024 | 5.159B |
| April 17, 2024 | 5.159B |
| April 16, 2024 | 5.159B |
| April 15, 2024 | 5.159B |
| Date | Value |
|---|---|
| April 12, 2024 | 5.229B |
| April 11, 2024 | 5.229B |
| April 10, 2024 | 5.229B |
| April 09, 2024 | 5.229B |
| April 08, 2024 | 5.229B |
| April 05, 2024 | 5.229B |
| April 04, 2024 | 5.229B |
| April 03, 2024 | 5.426B |
| April 02, 2024 | 5.267B |
| April 01, 2024 | 5.267B |
| March 28, 2024 | 5.267B |
| March 27, 2024 | 5.267B |
| March 26, 2024 | 5.403B |
| March 25, 2024 | 5.403B |
| March 22, 2024 | 5.403B |
| March 21, 2024 | 5.403B |
| March 20, 2024 | 5.403B |
| March 19, 2024 | 5.403B |
| March 18, 2024 | 5.307B |
| March 15, 2024 | 5.307B |
| March 14, 2024 | 5.307B |
| March 13, 2024 | 5.396B |
| March 12, 2024 | 5.396B |
| March 11, 2024 | 5.325B |
| March 08, 2024 | 5.325B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
2.865B
Minimum
Oct 21 2022
8.774B
Maximum
Aug 02 2021
6.007B
Average
5.856B
Median
Jan 08 2020
Market Cap Benchmarks
| Adaptimmune Therapeutics PLC | 283.67M |
| Biodexa Pharmaceuticals Plc | 5.218M |
| Verona Pharma PLC | 1.054B |
| NuCana PLC | 7.548M |
| Autolus Therapeutics PLC | 1.167B |
Market Cap Related Metrics
| PE Ratio | 29.94 |
| PS Ratio | 1.968 |
| Price to Book Value | 2.569 |
| Price to Free Cash Flow | 10.62 |
| Price | 50.90 |
| Earnings Yield | 3.34% |
| Operating PE Ratio | 9.369 |
| Normalized PE Ratio | 15.66 |